Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.33 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3487387 | 0.80 | KMT2A (0.44) | KMT2AATMALDH1A1PKMSLC1A2 | |
| SCHEMBL3801263 | 0.75 | KMT2A (0.46) | KMT2AATMALDH1A1PKMSLC1A2 | |
| SCHEMBL2332165 | 0.72 | ALDH1A1 (0.56) | KMT2AATMALDH1A1PKMSLC1A2 | |
| SCHEMBL1564210 | 0.72 | KMT2A (0.47) | KMT2AATMALDH1A1PKMSLC1A2 | |
| SCHEMBL604671 | 0.72 | ALDH1A1 (0.56) | KMT2AATMALDH1A1PKMSLC1A2 | |
| SCHEMBL9607 | 0.71 | KMT2A (0.43) | KMT2AATMALDH1A1PKMSLC1A2 | |
| SCHEMBL28393846 | 0.69 | ALDH1A1 (0.37) | KMT2AATMALDH1A1PKMSLC1A2 | |
| SCHEMBL30302184 | 0.69 | ALDH1A1 (0.53) | KMT2AATMALDH1A1PKMSLC1A2 | |
| Ethylene SCHEMBL29141463 | 0.69 | ALDH1A1 (0.53) | KMT2AATMALDH1A1PKMSLC1A2 | |
| Ethylene SCHEMBL8387032 | 0.69 | ALDH1A1 (0.53) | KMT2AATMALDH1A1PKMSLC1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5395924-A | Oligosaccharide or glycopeptide bound to lectin and conjugated with cell binding agent, improved targeting of cells for cytolysis | DANA-FARBER CANCER INSTITUTE, INC. (US) | 1995-03-07 | — | — | US | disclosed |
| US-5239062-A | Blocked lectins, methods and affinity support for making same using affinity ligands, and method of killing selected cell populations having reduced nonselective cytotoxicity | DANA-FARBER CANCER INSTITUTE, INC. (US) | 1993-08-24 | — | — | US | disclosed |